SI-BONE to Participate in MedTech Conference
SI-BONE, Inc. (NASDAQ: SIBN), a leading medical device company focused on addressing sacropelvic disorders, has announced exciting participation in a major industry event. The company will be engaging in the upcoming Truist Securities MedTech Conference, which is set to take place in Boston. During this event, the management team will present insights during a fireside chat, demonstrating their commitment to innovation and connection with the investment community.
Details of the Conference Presentation
The conference will occur in a networking-rich environment that attracts industry leaders and stakeholders. Although the specific date may change, management is scheduled to host a discussion at 10:00 a.m. Pacific Time, inviting investors and interested parties to register for the call. This opportunity aims to strengthen ties between SI-BONE and its investors through direct interaction and Q&A sessions.
Accessing the Conference Call
Participants interested in being part of the discussion are encouraged to register for the event. Live audio of the session will also be available on the company’s website under the Investors section. This ensures that those who cannot attend in person can still engage with the valuable insights shared during the conference.
About SI-BONE, Inc.
SI-BONE is renowned for its pioneering work in the field of minimally invasive surgery, specifically targeting sacropelvic disorders. Since the introduction of the iFuse Implant System in 2009, the company has achieved remarkable milestones. Over 4,500 physicians have successfully performed more than 120,000 procedures using SI-BONE’s innovative technologies, showcasing the effectiveness and reliability of their solutions in clinical settings.
Innovations and Clinical Evidence
SI-BONE stands out in the medical field due to its solid foundation of clinical evidence. The company supports its technologies with more than 160 peer-reviewed publications, including notable randomized controlled trials that highlight the benefits and viability of their surgical techniques. This robust clinical backing positions SI-BONE as a reliable choice for medical professionals dealing with sacropelvic issues.
Expanding Technological Frontiers
In addition to its pioneering innovations in the minimally invasive SI joint fusion area, SI-BONE has expanded its portfolio to encompass solutions targeting adjacent markets. These include challenges pertaining to adult deformity, spinopelvic fixation, sacropelvic fixation, and pelvic trauma. This strategic expansion reflects the company’s vision to enhance patient outcomes and advance surgical techniques across various fields.
Engaging with Investors
The opportunity for investors to connect with SI-BONE through events like the Truist Securities MedTech Conference underscores the company’s commitment to transparency and collaboration. This dual focus on innovation and investor relations aims to create a supportive ecosystem that benefits both patients and medical professionals.
Connect with SI-BONE
For those seeking further information about SI-BONE and its groundbreaking products, the company’s website offers extensive resources, including details about risks and benefits associated with their innovative solutions. The active engagement between SI-BONE and its investors, along with ongoing updates about their medical devices, reflects a healthy relationship fostering trust and cooperation.
SI-BONE is dedicated to continuous improvement and innovation, working diligently to make a significant impact on the treatment landscape for sacropelvic disorders.
Frequently Asked Questions
What topics will SI-BONE discuss at the conference?
SI-BONE will cover their innovative surgical approaches and advancements in treating sacropelvic disorders.
How can I participate in the conference?
Interested individuals can register online for the conference call through SI-BONE's website.
What makes SI-BONE a leader in its field?
SI-BONE has a strong track record of successful surgical procedures and substantial clinical evidence supporting its technologies.
Where can I find more information about SI-BONE’s products?
Additional information is available on SI-BONE's official website, including product details and updates.
How can I contact SI-BONE for investor relations?
Investors can reach out to Saqib Iqbal via email at investors@si-bone.com for inquiries.
